Neoadjuvant Endocrine Therapy in Breast Cancer Up-Regulates the Cytotoxic Drug Pump ABCG2 /BCRP, and May Lead to Resistance to Subsequent Chemotherapy

Clinical Breast Cancer - United States
doi 10.1016/j.clbc.2018.07.002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV